Showing results (171-180 of 464) with videos related to
Sort By:
Pageof 47
Blood|February 15, 1996
Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemiaN Robinson, J E Sanders, M C Benyunes, et al.Blood|August 1, 1990
Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogsF G Schuening, R Storb, S Goehle, et al.Blood|March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factorW I Bensinger, C H Weaver, F R Appelbaum, et al.Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.Blood|August 15, 1992
A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboonsR G Andrews, S H Bartelmez, G H Knitter, et al.Experimental Hematology|November 1, 1990
Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow graftsT P Loughran, R F Raff, T C Graham, et al.Transplantation|November 1, 1986
Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporineH J Deeg, H M Shulman, E Schmidt, et al.Transplantation|November 1, 1988
L-leucyl-L-leucine methyl ester treatment of canine marrow and peripheral blood cells. Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftmentR F Raff, E Severns, R Storb, et al.International Journal of Radiation Oncology, Biology, Physics|May 20, 1993
Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine modelR Storb, R F Raff, T Graham, et al.Cancer Treatment Reports|February 1, 1978
Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcomaA S Levine, F R Appelbaum, R G Graw, et al.Pageof 47